Engineers Gate Manager LP Biocryst Pharmaceuticals Inc Transaction History
Engineers Gate Manager LP
- $5.55 Billion
- Q1 2025
A detailed history of Engineers Gate Manager LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 113,054 shares of BCRX stock, worth $1.24 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
113,054
Previous 23,250
386.25%
Holding current value
$1.24 Million
Previous $174,000
386.78%
% of portfolio
0.02%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BCRX
# of Institutions
293Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$238 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$219 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$98 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$95.5 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$85.8 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $2.04B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...